Study of the predictive value of testosterone in androgen deprivation therapy for metastatic hormone-sensitive prostate cancer—the dual clinical research center for western and eastern China
Ultra-low T levels (<20 ng/dL) after 1-month ADT can be used as a reference standard for predicting survival outcomes and may guide treatment optimization in mHSPC.
Authors
- Dongsheng Ma (ORCID: https://orcid.org/0009-0001-4708-186X)
- Jianying Xi (ORCID: https://orcid.org/0000-0003-1028-3801)
- Zhang Xiao-guang (ORCID: https://orcid.org/0000-0002-0584-788X)
Institutions
- Xinjiang Medical University (CN)
- First Affiliated Hospital of Xinjiang Medical University (CN)
- Bozhou People's Hospital (CN)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2025-10-17
- DOI
- https://doi.org/10.3389/fendo.2025.1630862
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00